---
figid: PMC4049797__cbt-15-815-g4
figlink: /pmc/articles/PMC4049797/figure/F4/
number: ''
caption: Figure 4. A simplified model of dysregulated EGFR (RTKs)/PI3K/mTOR pathway
  in GBM and corresponding target therapies. (A) Multiple lesions cause constitutive
  activation of EGFR (RTKs)/PI3K/mTOR pathway. (B) Targeting different components
  in EGFR(RTKs)/PI3K/mTOR pathway based on patient tumor genetic profile.
pmcid: PMC4049797
papertitle: Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma
  response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384.
reftext: Yanni Zhu, et al. Cancer Biol Ther. 2014 Jun 1;15(6):815-822.
pmc_ranked_result_index: '57726'
pathway_score: 0.930795
filename: cbt-15-815-g4.jpg
figtitle: Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma
  response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384
year: '2014'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4049797__cbt-15-815-g4.html
  '@type': Dataset
  description: Figure 4. A simplified model of dysregulated EGFR (RTKs)/PI3K/mTOR
    pathway in GBM and corresponding target therapies. (A) Multiple lesions cause
    constitutive activation of EGFR (RTKs)/PI3K/mTOR pathway. (B) Targeting different
    components in EGFR(RTKs)/PI3K/mTOR pathway based on patient tumor genetic profile.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - AKT2
  - PIK3CA
  - PIK3R6
  - MTOR
  - AKT3
  - MFAP1
  - PIK3R5
  - PIK3R4
  - MUT
  - AKT1
  - PIK3CG
  - PIK3R3
  - PIK3CB
  - PIK3CD
  - Dacomitinib
  - PF-05212384
genes:
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Amp/mut
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Amp/mut
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: EGFR(RTKS)/PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals:
- word: Dacomitinib
  source: MESH
  identifier: C525726
- word: PF-05212384
  source: MESH
  identifier: C549060
diseases: []
---
